Cenk Sumen
No más puestos en curso
Fortuna: - $ al 31/03/2024
Perfil
Cenk Sumen worked as a Director at Thermo Fisher Scientific, Inc. and as a Senior Manager-Business Development at Minaris Regenerative Medicine LLC from 2014 to 2018.
He was also the Chief Scientific Officer at MaxCyte, Inc. from 2022 to 2024.
Currently, he is the Chief Technology Officer at Stemson Therapeutics, LLC.
Dr. Sumen received his undergraduate and doctorate degrees from Stanford University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
MAXCYTE, INC.
-.--% | 31/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Antiguos cargos conocidos de Cenk Sumen.
Empresas | Cargo | Fin |
---|---|---|
MAXCYTE, INC. | Chief Tech/Sci/R&D Officer | 23/01/2024 |
THERMO FISHER SCIENTIFIC | Director/Board Member | 01/04/2018 |
Minaris Regenerative Medicine LLC
Minaris Regenerative Medicine LLC Medical/Nursing ServicesHealth Services Minaris Regenerative Medicine LLC provides cell therapy services. It provides contract development and manufacturing organization (CDMO) services at current Good Manufacturing Practices (cGMP) standards, including clinical manufacturing, commercial manufacturing, and manufacturing development. The company was founded by Robert A. Preti and Andrew L. Pecora in 1997 and is headquartered in Allendale, NJ. | Corporate Officer/Principal | 01/04/2018 |
Stemson Therapeutics, LLC
Stemson Therapeutics, LLC Miscellaneous Commercial ServicesCommercial Services Stemson Therapeutics, LLC is a pre-clinical stage cell therapy company that aims to cure hair loss by using induced pluripotent stem cells to regenerate the critical cells required to grow hair. The company is based in La Jolla, CA, and is passionate about delivering a scientifically based, clinically tested cure for hair loss to the millions of hair loss sufferers who seek help for their hair loss condition. Stemson's breakthrough innovation uses a novel cell engineering process to produce the cell types required to regenerate hair follicles. The company was founded in 2018 by Geoff Hamilton and a team of world-class scientists, advisors, and collaborators. | Chief Tech/Sci/R&D Officer | - |
Formación de Cenk Sumen.
Stanford University | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
MAXCYTE, INC. | Health Technology |
THERMO FISHER SCIENTIFIC | Health Technology |
Empresas privadas | 2 |
---|---|
Minaris Regenerative Medicine LLC
Minaris Regenerative Medicine LLC Medical/Nursing ServicesHealth Services Minaris Regenerative Medicine LLC provides cell therapy services. It provides contract development and manufacturing organization (CDMO) services at current Good Manufacturing Practices (cGMP) standards, including clinical manufacturing, commercial manufacturing, and manufacturing development. The company was founded by Robert A. Preti and Andrew L. Pecora in 1997 and is headquartered in Allendale, NJ. | Health Services |
Stemson Therapeutics, LLC
Stemson Therapeutics, LLC Miscellaneous Commercial ServicesCommercial Services Stemson Therapeutics, LLC is a pre-clinical stage cell therapy company that aims to cure hair loss by using induced pluripotent stem cells to regenerate the critical cells required to grow hair. The company is based in La Jolla, CA, and is passionate about delivering a scientifically based, clinically tested cure for hair loss to the millions of hair loss sufferers who seek help for their hair loss condition. Stemson's breakthrough innovation uses a novel cell engineering process to produce the cell types required to regenerate hair follicles. The company was founded in 2018 by Geoff Hamilton and a team of world-class scientists, advisors, and collaborators. | Commercial Services |
- Bolsa de valores
- Insiders
- Cenk Sumen